An anonymized, de-identified registry study protocol to determine the effectiveness and safety of weight loss with enavogliflozin in patients with type 2 diabetes mellitus - Hyunji Sang; Sunyoung Kim; Jiyoung Hwang; Selin Woo; Jaewon Kim; Dong Keon Yon; Sang Youl Rhee (PLoS ONE, 2025)